A022
RISK STRATIFICATION OF LATERAL NECK RECURRENCE FOR PN1A PAPILLARY THYROID CANCER BASED ON THE NUMBER OF CENTRAL METASTATIC LYMPH NODES AND PRIMARY TUMOR SIZE
Endocrine Surgery
Siyuan Xu; Hui Huang; Shaoyan Liu; Jie Liu
Department of Head and Neck Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
A023
NEOADJUVANT SELECTIVE RET INHIBITOR FOR MEDULLARY THYROID CANCER: A CASE SERIES
Kevin J Contrera, MD, MPH; Maria K Gule-Monroe, MD; Maria E Cabanillas, MD; Mimi I Hu, MD; Naifa L Busaidy, MD; Ramona Dadu, MD; Steven G Waguespack, MD; Jennifer Wang, MD; Jeffery Myers, MD, PhD; Elizabeth G Grubbs, MD; Vivek Subbiah, MD; Michelle D Williams, MD; Mark E Zafereo, MD
UT MD Anderson Cancer Center
A024
SHARED DECISION-MAKING IN THE MANAGEMENT OF INDETERMINATE THYROID NODULES
David Forner, MD, MSc1; Victoria Taylor, BA1; Christopher W Noel, MD2; Brooke Turner, MD1; Paul Hong, MD, MSc1; Stephanie Johnson-Obaseki, MD, MPH3; David P Goldstein, MD, MSc2; Matthew H Rigby, MD, MPH1; S. Mark Taylor, MD1; Jonathan R Trites, MD1; Martin Corsten, MD1
1Dalhousie University; 2University of Toronto; 3University of Ottawa
A025
HEALTH CARE DISPARITIES AND RATES OF MALIGNANCY AMONGST CHILDREN WITH SINGLE THYROID NODULES
Z. Jason Qian, MD1; Eric Pineda, BS2; Hilary Seeley, MD1; Gary Hartman, MD1; Julia Noel, MD1; Lisa A Orloff, MD1; Kara D Meister, MD1
1Stanford University; 2Tulane University
A026
COMPARISON OF RISK FACTORS AND POSTOPERATIVE OUTCOMES IN PRIMARY AND SECONDARY/TERTIARY HYPERPARATHYROIDISM
Ryan M Kong, BS; Jennifer Liang, MD; Natalya Chernichenko, MD
SUNY Downstate Health Sciences University
A027
FACTORS ASSOCIATED WITH REFUSAL OF SURGERY IN DIFFERENTIATED THYROID CARCINOMA
Aman Prasad, BS1; Ryan M Carey, MD2; Robert M Brody, MD2; Steven B Cannady, MD2; Jason G Newman, MD2; Jason Brant, MD2; Karthik Rajasekaran, MD2
1Perelman School of Medicine at the University of Pennsylvania; 2Department of Otorhinolaryngology: Head and Neck Surgery, University of Pennsylvania, Perelman School of Medicine
A029
IMPLICATIONS OF EMERGENCY DEPARTMENT PRESENTATION FOR HEAD AND NECK CANCER SURGERY
Functional Outcomes / Quality
James A Gallogly, MD; Jennifer V Brinkmeier, MD; Sean T Massa, MD, MSCI
Saint Louis University School of Medicine
A030
ASSESSING THE NUTRITIONAL RISK INDEX AS A PREDICTOR OF POSTOPERATIVE COMPLICATIONS IN HEAD AND NECK CANCER SURGERY
Rushi Patel, BA; Vraj P Shah, BS; Prayag Patel, MD; Jean A Eloy, MD, FACS, FARS
Rutgers New Jersey Medical School
A031
OPIOID PRESCRIBING PATTERNS ACROSS HEAD AND NECK CANCER ONCOLOGY TEAMS AND OTOLARYNGOLOGY PROVIDERS
Neelam Phalke, MD1; Christine Settoon, MD1; Michael Olejniczak, MD2; John N Poche, MD1; Delaney Sheehan, MD3; Lee McDaniel, PhD4; Ashley C Mays, MD1
1Louisiana State University Otolaryngology; 2Louisiana State University General Surgery; 3University of Alabama Otolaryngology; 4Louisiana State University Department of Public Health
A032
APPLICATION OF FIBRIN SEALANT TO THE TRANSORAL SURGICAL DEFECT SIGNIFICANTLY REDUCES OPIOID USE AND POSTOPERATIVE PAIN
Samantha M Cleveland, MD1; Stacey L Tannenbaum, PhD2; Crista Horton, MD2; Ryan H Sobel, MD3
1Department of Surgery, Broward Health Medical Center, Fort Lauderdale, Florida, U.S.A; 2Broward Health Research Institute, Broward Health Medical Center, Fort Lauderdale, Florida, U.S.A; 3Division of Head & Neck Surgery and Oncology, Department of Surgery, Broward Health Medical Center, Fort Lauderdale, Florida, U.S.A
AHNS Annual Meeting
Held during the Combined Otolaryngology
Spring Meetings (COSM)
April 27-28, 2022
Hyatt Regency Dallas
Dallas, TX